Vincerx Pharma Files Proxy Statement for Annual Meeting

TL;DR

Vincerx Pharma (VINC) proxy filed for Aug 12 meeting - vote on directors & pay.

AI Summary

Vincerx Pharma, Inc. filed its definitive proxy statement (DEF 14A) on July 8, 2024, for its annual meeting on August 12, 2024. The filing details the company's governance and proposals for shareholder vote, including the election of directors and executive compensation.

Why It Matters

This filing provides shareholders with crucial information about the company's leadership, executive pay, and key decisions to be made at the upcoming annual meeting, impacting corporate governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently present new financial risks.

Key Players & Entities

• Vincerx Pharma, Inc. (company) — Registrant
• 0001796129 (company) — Central Index Key
• 20240812 (date) — Annual Meeting Date
• 20240708 (date) — Filing Date

FAQ

Key Financial Figures

• $25.90 — f our current employees were hired, was $25.90 and $9.48, respectively. The high and l
• $9 — nt employees were hired, was $25.90 and $9.48, respectively. The high and low clos
• $10.44 — w closing price of our common stock was $10.44 and $0.64 during 2022, $1.90 and $0.63
• $0.64 — rice of our common stock was $10.44 and $0.64 during 2022, $1.90 and $0.63 during 202
• $1.90 — stock was $10.44 and $0.64 during 2022, $1.90 and $0.63 during 2023, and $8.06 and $0
• $0.63 — $10.44 and $0.64 during 2022, $1.90 and $0.63 during 2023, and $8.06 and $0.57 during
• $8.06 — 2022, $1.90 and $0.63 during 2023, and $8.06 and $0.57 during 2024 through the Recor
• $0.57 — 90 and $0.63 during 2023, and $8.06 and $0.57 during 2024 through the Record Date. Th
• $20.91 — mon stock was 5 Table of Contents $20.91 at the end of calendar year 2020, $10.1
• $10.19 — 20.91 at the end of calendar year 2020, $10.19 at the end of calendar year 2021, $1.02
• $1.02 — 10.19 at the end of calendar year 2021, $1.02 at the end of calendar year 2022, and $
• $1.18 — 2 at the end of calendar year 2022, and $1.18 at the end of calendar year 2023. The c
• $0.737 — k on July 2, 2024, the Record Date, was $0.737. As a result of this significant decl
• $7.00 — s having an exercise price in excess of $7.00 per share, and approximately 25% of suc
• $12.00 — s having an exercise price in excess of $12.00 per share. Many of these grants have be

Filing Documents

• d787209ddef14a.htm (DEF 14A) — 207KB
• g787209g01g01.jpg (GRAPHIC) — 198KB
• g787209g02g02.jpg (GRAPHIC) — 220KB
• g787209g53p02.jpg (GRAPHIC) — 35KB
• 0001193125-24-176281.txt ( ) — 832KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS ANDMANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS ANDMANAGEMENT 19 STOCKHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING 21 OTHER MATTERS 21 WHERE YOU CAN FIND ADDITIONAL INFORMATION 21 i Table of Contents 260 Sheridan Avenue, Suite 400 Palo Alto, CA 94306 PROXY STATEMENT Information Concerning Voting and Solicitation This Proxy Statement (this Proxy Statement) is being furnished to you in connection with the solicitation by the board of directors of Vincerx Pharma, Inc., a Delaware corporation (we, us, our, Vincerx or the Company), of proxies in the accompanying form to be used at the Special Meeting of Stockholders of the Company to be held virtually on Monday, August 12, 2024 at 10:00 a.m., Pacific Time, and any adjournments or postponements thereof (the Special Meeting). This Proxy Statement is being mailed to stockholders on or about July 10, 2024. Questions and Answers About the Proxy Materials and the Special Meeting Why am I receiving these materials? Our board of directors is soliciting your proxy to vote at the Special Meeting, including at any adjournments or postponements of the meeting. The Special Meeting will be held virtually. You are invited to attend the Special Meeting via live audio webcast to vote electronically on the proposals described in this Proxy Statement. However, you do not need to attend the meeting to vote your shares. Instead, you may follow the instructions below to submit your proxy by Internet or mail. We are sending this Proxy Statement to our stockholders of record and beneficial owners as of the close of business on July 2, 2024, which is the record date for the Special Meeting (the Record Date). Stockholders are encouraged to vote and submit proxies in advance of the Special Meeting by Internet or mail as early as possible to ensure their votes are counted. What proposal will be voted on at the Special Meeting? One proposal will be voted on at the Special Meeting: Proposal 1: The approval of

View Full Filing

View this DEF 14A filing on SEC EDGAR